Gilead Sciences (GILD) Non-Current Debt (2010 - 2026)

Gilead Sciences (GILD) has reported Non-Current Debt for 17 consecutive years, with $26.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt rose 5.21% year-over-year to $26.2 billion; the trailing twelve-month figure through Jun 2026 stood at $26.2 billion (up 5.21% YoY), and the FY2025 full-year result was $24.9 billion, down 6.64% from the prior year.
• Non-Current Debt climbed to $26.2 billion in Q2 2026 per GILD's latest filing, from $22.2 billion in the prior quarter.
• Across five years, Non-Current Debt topped out at $26.7 billion in Q4 2024 and bottomed at $22.2 billion in Q1 2026.
• Historically, Non-Current Debt has averaged $25.0 billion across 5 years, with a median of $25.1 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Non-Current Debt dropped 13.12% in 2022, then advanced 7.28% in 2025.
• Over 5 years, Non-Current Debt stood at $25.2 billion in 2022, then declined by 0.96% to $25.0 billion in 2023, then increased by 6.9% to $26.7 billion in 2024, then slipped by 6.64% to $24.9 billion in 2025, then climbed by 5.25% to $26.2 billion in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $26.2 billion, $22.2 billion, and $24.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.